S
Sylvester Sterioff
Researcher at Mayo Clinic
Publications - 77
Citations - 2593
Sylvester Sterioff is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Transplantation & Kidney transplantation. The author has an hindex of 28, co-authored 77 publications receiving 2540 citations. Previous affiliations of Sylvester Sterioff include Louisiana State University & University of Rochester.
Papers
More filters
Journal ArticleDOI
Postsplenectomy Sepsis and Mortality in Adults
TL;DR: The low risk of fulminant sepsis aftersplenectomy in the general adult population justifies a policy of individualization of each case as to the relative merits of splenectomy v splenic preservation.
Journal ArticleDOI
Improved Scoring System to Assess Adult Donors For Cadaver Renal Transplantation
Scott L. Nyberg,Arthur J. Matas,Walter K. Kremers,Jeffrey D. Thostenson,Timothy S. Larson,Mikel Prieto,Michael B. Ishitani,Sylvester Sterioff,Mark D. Stegall +8 more
TL;DR: The improved scoring system developed from a large population database provides a quantitative approach to evaluation of marginal kidneys and may improve allocation of these organs in cadaver renal transplantation.
Journal ArticleDOI
Increased bile duct complications in liver transplantation across the ABO barrier.
L. Sanchez-Urdazpal,Kenneth P. Batts,Gregory J. Gores,S. B. Moore,Sylvester Sterioff,Russell H. Wiesner,Ruud A.F. Krom +6 more
TL;DR: A high incidence of biliary and hepatic artery complications and decreased graft survival in liver transplantation were found, and an immunologic injury to the bile duct epithelium and/or to vascular endothelium is suspected.
Journal ArticleDOI
Survival Rates of 2,728 Patients With End-Stage Renal Disease*
Wendy L. Hellerstedt,William J. Johnson,Nancy L. Ascher,Carl M. Kjellstrand,Russell Knutson,Fred L. Shapiro,Sylvester Sterioff +6 more
TL;DR: Analysis of survival rates by treatment modality for a control group indicated that minimal differences were evident by the third year among the four treatment groups, however, recipients of cadaver grafts had lower survival rates than all other groups, even those maintained by in-center hemodialysis.
Journal ArticleDOI
Subclinical rejection in tacrolimus-treated renal transplant recipients.
James M. Gloor,Ari J. Cohen,Donna J. Lager,Joseph P. Grande,Mary E. Fidler,Jorge A. Velosa,Timothy S. Larson,Thomas R. Schwab,Matthew D. Griffin,Mikel Prieto,Scott L. Nyberg,Sylvester Sterioff,Walter K. Kremers,Mark D. Stegall +13 more
TL;DR: The incidence of subclinical rejection early after kidney transplantation is extremely low in tacrolimus-treated patients in whom early rejections are aggressively treated, suggesting that surveillance biopsies may not be necessary with this regimen.